Cargando…

Inflammation-based scores as predictors of treatment response in advanced adrenocortical carcinoma

Treatment for advanced adrenocortical carcinoma (ACC) consists of mitotane alone or combined with etoposide, doxorubicin, and cisplatin (EDP). Although both therapies are widely used, markers of response are still lacking. Since inflammation-based scores have been proposed as prognostic factors in A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mangone, Alessandra, Altieri, Barbara, Detomas, Mario, Prete, Alessandro, Abbas, Haider, Asia, Miriam, Elhassan, Yasir S, Mantovani, Giovanna, Ronchi, Cristina L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083578/ https://www.ncbi.nlm.nih.gov/pubmed/36715606 http://dx.doi.org/10.1530/ERC-22-0372

Ejemplares similares

Coincidence of primary adrenocortical carcinoma and melanoma: three CASE reports
por: Ko, Ye Lynn, et al.
Publicado: (2023)

OR04-5 Circulating Cell-Free DNA-Based Biomarkers For Prognostication and Disease Surveillance in Adrenocortical Carcinoma
por: Altieri, Barbara, et al.
Publicado: (2022)

MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma
por: Detomas, Mario, et al.
Publicado: (2022)

A case of unilateral post-COVID-19 adrenal haemorrhage and follow-up during pregnancies
por: Mangone, Alessandra, et al.
Publicado: (2022)

Modified GRAS Score for Prognostic Classification of Adrenocortical Carcinoma: An ENSAT Multicentre Study
por: Elhassan, Yasir, et al.
Publicado: (2021)

S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study
por: Elhassan, Y S, et al.
Publicado: (2021)

Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues?
por: Sbiera, Iuliu, et al.
Publicado: (2021)

Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing’s Syndrome: Results From a Single Center Cohort Study
por: Detomas, Mario, et al.
Publicado: (2022)

Prognostic Role of Targeted Methylation Analysis in Paraffin-embedded Samples of Adrenocortical Carcinoma
por: Lippert, Juliane, et al.
Publicado: (2022)

FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma
por: Tamburello, Mariangela, et al.
Publicado: (2022)

SUN-LB22 PLK1 as a New Treatment Target for Adrenocortical Carcinoma
por: Smith, Gabrielle, et al.
Publicado: (2020)

Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma
por: Chifu, Irina, et al.
Publicado: (2020)

Livin/BIRC7 expression as malignancy marker in adrenocortical tumors
por: Altieri, Barbara, et al.
Publicado: (2016)

Evaluation of the Molecular Pathogenesis of Adrenocortical Tumors by Whole-Genome Sequencing
por: Neininger, Kerstin, et al.
Publicado: (2021)

Identifying New Potential Biomarkers in Adrenocortical Tumors Based on mRNA Expression Data Using Machine Learning
por: Marquardt, André, et al.
Publicado: (2021)

Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma
por: Liang, Raimunde, et al.
Publicado: (2020)

THU617 Prolonged Exposure To Target Mitotane Concentrations Is Associated With Better Recurrence-free Survival In Patients With Adrenocortical Carcinoma On Adjuvant Treatment
por: Puglisi, Soraya, et al.
Publicado: (2023)

CYP2W1 Is Highly Expressed in Adrenal Glands and Is Positively Associated with the Response to Mitotane in Adrenocortical Carcinoma
por: Ronchi, Cristina L., et al.
Publicado: (2014)

Management of Patients With Glucocorticoid-Related Diseases and COVID-19
por: Chifu, Irina, et al.
Publicado: (2021)

Was It an Adrenocortical Adenoma or an Adrenocortical Carcinoma? Limitation of the Weiss Scoring System in Determining the Malignant Potential of Adrenocortical Tumor: Report on Two Cases
por: Wong, Cheuk-Lik, et al.
Publicado: (2022)

Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study
por: Remde, Hanna, et al.
Publicado: (2023)

Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic Implications
por: Sbiera, Iuliu, et al.
Publicado: (2021)

Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma
por: Landwehr, Laura-Sophie, et al.
Publicado: (2020)

Succinate mediates inflammation-induced adrenocortical dysfunction
por: Mateska, Ivona, et al.
Publicado: (2023)

Novel AIP mutation in exon 6 causing acromegaly in a German family
por: Detomas, M., et al.
Publicado: (2023)

Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma
por: Kimpel, Otilia, et al.
Publicado: (2022)

Approach to the Patient With Adrenal Hemorrhage
por: Elhassan, Yasir S, et al.
Publicado: (2022)

Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma
por: Chortis, Vasileios, et al.
Publicado: (2019)

Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical Carcinoma
por: Puglisi, Soraya, et al.
Publicado: (2020)

Special Issue: Present and Future of Personalised Medicine for Endocrine Cancers
por: Ronchi, Cristina L., et al.
Publicado: (2022)

Histological scores and tumor size on stage II in adrenocortical carcinomas
por: Oliveira, Rui Caetano, et al.
Publicado: (2021)

SUN-350 Sterol-O-Acyl Transferase 1 Protein Expression Alone Is Not Sufficient to Predict Response to Mitotane Treatment in Adrenocortical Carcinoma
por: Weigand, Isabel, et al.
Publicado: (2019)

Causes, Patterns, and Severity of Androgen Excess in 1205 Consecutively Recruited Women
por: Elhassan, Yasir S, et al.
Publicado: (2018)

Novel Insights into the Molecular Regulation of Ribonucleotide Reductase in Adrenocortical Carcinoma Treatment
por: Bothou, Christina, et al.
Publicado: (2021)

Intratumor heterogeneity of prognostic DNA-based molecular markers in adrenocortical carcinoma
por: Jouinot, Anne, et al.
Publicado: (2020)

Immunotherapy in Adrenocortical Carcinoma: Predictors of Response, Efficacy, Safety, and Mechanisms of Resistance
por: Araujo-Castro, Marta, et al.
Publicado: (2021)

Single Nucleotide Polymorphism Array Profiling of Adrenocortical Tumors - Evidence for an Adenoma Carcinoma Sequence?
por: Ronchi, Cristina L., et al.
Publicado: (2013)

Suspected metastatic adrenocortical carcinoma revealing as pulmonary Kaposi sarcoma in adrenal Cushing’s syndrome
por: Bala, Margarita, et al.
Publicado: (2014)

Case Report: Consecutive Adrenal Cushing’s Syndrome and Cushing’s Disease in a Patient With Somatic CTNNB1, USP8, and NR3C1 Mutations
por: Detomas, Mario, et al.
Publicado: (2021)

Adrenocortical Carcinoma
por: Berruti, Alfredo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_74vlo94cdlm88m1fmg1nrb0sam